Ensysce Biosciences: Funding, Investors & Team (Sep 2026)
We’re a biotech company committed to stemming the prescription drug abuse epidemic. Our proprietary prodrug technologies: abuse resistant TAAP™ and overdose resistant MPAR™ are designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription drug abuse. In addition to working with all known prescription opioid drugs, our abuse-resistant drug technologies TAAP™ and MPAR™ have broad potential across a variety of other drugs with the possibility of abuse. For example, we currently have multiple TAAP™ products in the pipeline including one for ADHD.
Ensysce Biosciences has raised $62.0M across 2 funding rounds on record, the most recent an undisclosed round of $2.0M announced in Apr 2026.
That round is below the $4.8M median round size for Administrative Services companies tracked on FundedIQ over the last two years.
Ensysce Biosciences Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Ensysce Biosciences Funding Rounds
Ensysce Biosciences raised $60.0M in an undisclosed round announced in Jan 2021.
5.3 years later, an undisclosed round of $2.0M was announced in Apr 2026.
Ensysce Biosciences Founders and Leadership Team
Contact details for the Ensysce Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Ensysce Biosciences Funding Compared to Other Administrative Services Startups
Ensysce Biosciences' latest round of $2.0M is below the median round in Administrative Services. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ensysce Biosciences in Administrative Services and San Diego
Companies Similar to Ensysce Biosciences
BrightPlan's mission is to make financial wellness attainable for everyone. BrightPlan is the first financial…
SupplyCaddy produces a range of disposable paper products, which include designs such as packaging, paper,…
Easy Aerial is a leading provider of autonomous drone-based monitoring solutions for commercial, government,…
COR is the next-generation solution for creative and professional teams that intelligently suggests how to…
Rocketlane is building a unified workspace that enables customers to collaborate on onboarding projects.…
Warp is the AI-native Employee Management platform for ambitious companies. Payroll, HR, compliance, benefits…
QuickSecure is a safety and operations company that offers a platform to monitor and mitigate security risks…
Vetano is a proof-first hiring marketplace. Every candidate completes government-ID verification, then…
Niural, named after neural networks, is a modern artificial intelligence platform that revolutionizes the…
NukuDo provides workforce development and staffing services for the cybersecurity industry. Its core offering…
Cargofy it's a mobile assistant, kind of a "Siri" but for truck drivers. We help truckers access to high…
Workmatch is a employment tech company that offers a platform to help frontline workers find and land jobs.
Ensysce Biosciences Funding FAQs
What does Ensysce Biosciences do?
We’re a biotech company committed to stemming the prescription drug abuse epidemic. Our proprietary prodrug technologies: abuse resistant TAAP™ and overdose resistant MPAR™ are designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription drug abuse. In addition to working with all known prescription opioid drugs, our abuse-resistant drug technologies TAAP™ and MPAR™ have broad potential across a variety of other drugs with the possibility of abuse. For example, we currently have multiple TAAP™ products in the pipeline including one for ADHD.
How much funding has Ensysce Biosciences raised?
Ensysce Biosciences has raised $62.0M across 2 rounds on record. The most recent is an undisclosed round of $2.0M announced in Apr 2026.
When did Ensysce Biosciences last raise funding?
Ensysce Biosciences' most recent funding round on record is an undisclosed round of $2.0M, announced in Apr 2026.
Who is the CEO of Ensysce Biosciences?
Lynn Kirkpatrick is listed as CEO at Ensysce Biosciences.
Where is Ensysce Biosciences headquartered?
Ensysce Biosciences is based in San Diego, California, United States.
How many employees does Ensysce Biosciences have?
Ensysce Biosciences is in the 11-50 employee band.
How does Ensysce Biosciences' funding compare to other Administrative Services startups?
Ensysce Biosciences' latest round of $2.0M is below the $4.8M median round size for Administrative Services companies on FundedIQ across 1,897 tracked companies over the last two years.
About FundedIQ's Ensysce Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ensysce Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.